Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Utility Patent
1999-01-06
2001-01-02
Graser, Jennifer (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S193100, C424S197110, C424S282100, C424S203100, C536S123100
Utility Patent
active
06168796
ABSTRACT:
FIELD OF THE INVENTION
This application relates to immunostimulatory oligosaccharide compositions and methods of making and using them. In particular, the compositions comprise
S. penumococcus
serotype 8 oligosaccharides.
References
The following references are cited in the application at the relevant portion of the application.
Anderson, P., Infect. Immun. 39:233, 1983
Anderson, P. W., Immunogenic Conjugates, U.S. Pat. No. 4,673,574, 1987.
Anderson, P., Pichichero, M. E., and Insel, R. A., J. Clin. Invest. 76:52, 1985a.
Anderson, P., Pichichero, M. E., and Insel, R. A., J. Pediatr. 107:346, 1985b.
Anderson, P. W., Pichichero, M. E., Insel, R. A., Betts, R., Eby, R., and Smith, D. J., J. Immunol, 137:1181, 1986.
Anderson, P. W., Pichichero, M. E., Stein, E. C., Porcelli, S., Betts, R. F., Connuch, D. M., Korones, D., Insel, R. A., Zabradnick, J. M., and Eby, R., J. Immunol. 142:2464, 1989.
Avery, O. T. and Goebel, W. F., J. Exp. Med. 50:533, 1929.
Barro, A., Dogan, R., Prued'homme, J. L., Bajart, A., Danue, B. and Fritzell, B., Vaccine, II:1003, 1993.
Bixler, G. S. and Pillai, S., The cellular basis of the immune response to conjugate vaccines in “Conjugate Vaccines. Contributions to microbiology and immunology”, J. M. Creese and R. E. Lewis, eds., Kargen, Basel, 1989.
Bolan G., Broome, C. V., Fracklam, R. R., Pitkaytis, B. D., Fraser, D. W., and Schlech, W. F, III, Ann. Internal Med. 104:1, 1986.
Borgano, J. M., Mclean, A. A., Vella, P. P., Canepa, I., Davidson, W. L., and Hilleman, M. R., Proc. Soc. Exp. Biol. Med. 157:148, 1978.
Broome, C. V., Facklam, R. R., and Fraser, D. W., N. Engl. J. Med. 303:549, 1980.
Bruyn, G. A. W., and van Furth, R., Eur. J. Clin. Microbiol. Infect. Dis., 10:897, 1991.
Chudwin, D. S., Artrip, S. C., Korenbilt, A., Schiffman, G., and Rao, S., Infect. Immun. 50:213, 1985.
Connelly, K. K., and Starke, J. R., Sem. Resp. Inf. 6:209, 1991.
Cryz, S. J., and F{umlaut over (u)}rer, E., Conjugate vaccine against infections by gram-negative bacteria, method for its preparation and use, U.S. Pat. No. 4,771,127, 1988.
Eby, R., Koster, M., Hogerman, D. and Malinoski, F., Pneumococcal Conjugate Vaccines, in “Modern Approaches to New Vaccines Including Prevention of AIDS”, E. Norrby, F. Brown, R. Chanock and H. Ginsberg, eds., Cold Spring Harbor Laboratory Press, New York, 1994.
Fattom, A., Lue, C., Szu, S. C., Mestecky, J., Schiffman, G., Brylar, D., Vann., W. F., Watson, D., Kimzey, L. M., Robbins, J. B. and Schneerson, R., Infect. and Immun. 58:2309, 1990.
Fattom, A., Vann, W. F., Szu, S. C., Schneerson, R., Robbins, J. B., Chu, C., Sutton, A., Vickers, J. C., London, W. T., Curfman, B., Hardagree, M. C., and Shiloach, J. Infect. Immun. 56:2292, 1988.
Forester, H. L., Jahnigen, D. W., and LaForce, F. M., Am. J. Med. 83:425, 1987.
Guar, A., Arunan, K., Singh, O. and Talwar, G. P., Int. Immunol. 2:151, 1990.
Giebink, G. S., Koskela, M., Vella, P. P., Haris, M. and Chap, T. L., J. Inf. Dis. 167:347, 1993.
Goebel, W. F. and Avery, O. T., J. Exp. Med. 50:521, 1929.
Gordon, L. K., Polysaccharide-exotoxoid conjugate vaccines, U.S. Pat. No. 4,619,828, 1986.
Gordon, L. K.,
Haemophilus influenzae
b polysaccharide-diphtheria toxoid conjugate vaccine, U.S. Pat. No. 4,644,059, 1987.
Hazelwood, M., Nusrat, R., Kumararatne, D. S., Goodal, M., Raykundalia, C., Wang, D. G., Joyce, H. J., Milford-Wards, A., Forte, M. and Pahor, A., Clin. Exp. Immunol. 93:157, 1993.
Hakamori, S. and Kannagi, R., Carbohydrate antigens in higher animals, in “Handbook of experimental immunology—vol. 1”, D. M. Weir, L. A. Herzenberg, C. Blackwell and L. A. Herzenberg, eds., Blackwell, Oxford, 1986.
Heidelberger, M. and Avery, O. T., J. Exp. Med. 38,73, 1923.
Hilleman, M. R., Carlson, A. J., Jr., McLean, A. A., Vella, P. P., Weibel, R. E., and Woodhour, A. F., Rev. Infect. Dis. 3 (suppl):S31, 1981.
Jennings, H. J., and Lugowski, C., Immunogenic polysaccharide-protein conjugates, Canadian Patent No. 1,181,344, 1985.
Jennings, H. J., Roy, R., and Gamian, A. J., Modified menigococcal group b polysaccharide for conjugate vaccine, Canadian Patent No. 1,261,320, 1989.
Jones, J. K. N. and Perry, M. B., J. Am. Chem. Soc. 79:2787, 1957.
Kenne, L. and Lindberg, B., Bacterial polysaccharides in “The polysaccharides—Vol 2”, G. O. Aspinall, Ed., Academic Press, New York, 1983.
Lee, C. J., Banks, S. D. and Li, J. P., Crit. Rev. Microbio. 18:89, 1991.
Lees, A., Finkelman, F., Inman, J. K., Witherspoon, K., Johnson, P., Kennedy, J. and Mond, J. J., and Vaccine 12:1160, 1994.
Lock, R. A., Hansman, D., and Paton, J. C., Microbial Pathogen. 12:137, 1992.
Madore, D. V., Jackson, C. L., Phipps, D. C., Penridge Pediatric Association, Popejoy, L. A., Eby, R., and Smith, D. H., Pediatric, 85:331, 1990.
Malcolm, A. J., Messner, P., Sleytr, U. B., Smith, R. H., and Unger, F. M., Crystalline bacterial cell surface layers (S-layers) as combined carrier/adjuvants for conjugate vaccines, in “Immobilized Macromolecules: Application Potentials, ” U. B. Sleytr, P. Messner, D. Pum and M. Sara, eds, Springer-Verlag, London, 1993a.
Malcolm, V. J., Best, M. W., Szarka, R. J., Mosleh, Z., Unger, F. M., Messner, P. and Sleytr, U. B., Surface layers of
Bacillus alvei
as a carrier for a
Streptococcus pneumoniae
conjugate vaccine in “Adances in Bacterial Paracrystalline Surface Layers, ” T. J. Beveridge and S. F. Koval, eds., Plenum Press, New York, 1993b.
Mandell, G. L., “Principles and Practice of Infectious Diseases,” Churchill Livingston, New York, 1990.
Marburg, S., Jorn, D., Tolman, R. L., Arison, B., McCauley, J., Kniskern, P. J., Hagopian, A., and Vella, P. O., J. Am. Chem. Soc. 108:5282, 1986.
Marburg, S., Tolman, R. L., and Kniskern, P. J., Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigenerica spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency, U.S. Pat. No. 4,695,624, 1987.
Marburg, S., Kniskern, P. J., and Tolman, R. L., Covalently-modified bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers and methods of preparing such polysaccharides and conjugates and of confirming covalency, U.S. Pat. No. 4,882,317, 1989.
Mufson, M. A., Hughey, D., and Lydick, E., J. Infect. Dis. 151:749, 1985.
Mufson, M. A., Krause, H. E., Schiffman, G., and Hughey, D. E., Am. J. Med. Sci. 293:279, 1987.
Nielsen, S. V., and Henrichsen, J., Scand. J. Infect. Dis. 25:165, 1993.
Paton, J. C., Lock, R. A., Lees, C. J., Li, J. P., Berry, A. M., Mitchell, T. J., Andrew, P. W., Hansman, D., and Boulnois, G. J., Infect. Immun. 59:2297, 1991.
Peeters, C. C. A. M., Tenbergen-Meekes, A. M., Poolman, J. T., Berutett, M., Zegers, B. J. M. and Rijkers, G. T., Infect. Immun. 59:3504, 1991.
Penney, C. L., Michon, F., and Jennings, H. J., Improved Vaccine Compositions, WO 92/04951, 1992.
Perlmutter, R. M., Hansburg, D., Briles, D. E., Nicolotti, R. A., and Davie, J. M., J. Immunol. 121:566, 1978.
Porro, M., Oligosaccharide Conjugate Vaccines, Canadian Patent No. 2 052 323, 1992.
Porro, M., and Costantino, P., Glycoproteineic conjugates having trivalent immunogenic activity, U.S. Pat. No. 4,711,779, 1987.
Porro, M., Oligosaccharide conjugate vaccines, U.S. patent application Ser. No. 07/590,649, 1990.
Saunders, L. A. M., Rijkers, G. T., Kuis, W., Tenbergen-Meekes, A. J., de Graff-Meeker, B. R., Hiemstra, I. and Zegers, B. J. M., J. Allergy Clin. Immunol. 91:110, 1993.
Schidt, R. A., Boyd, J. F., McCracken, J. D., Schiffman, G., and Giolma, J. P., Med. Pediatr. Oncol. 11,305, 1983.
Schneerson, R., Barrera, O., Sutton, A., and Robins, J. B., J. Exp. Med. 152:361, 1980.
Schneerson, R., Robbins, J. B., Chu, C., Sutton, A., Vann, W., Vickers, J. C., London, W. T., Curfman, B., and Hardegree, M. C., Infect. Immun. 45:582, 1984.
Schneerson, R., Robbins, J. B., Parke, J. C., Bell, C., Schlesselman, J. J., Sutton, A., Wang, Z., Schiffman, G., Karpas, A., and Shiloach, J., Infect. Immun. 52:519, 1986.
Schneerson, R., Levi, L., Robbins, J. B., Bryla, D. M.,
Alberta Research Council
Burns Doane Swecker & Mathis L.L.P.
Graser Jennifer
LandOfFree
Immunostimulating activity of Streptococcus pneumoniae... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunostimulating activity of Streptococcus pneumoniae..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunostimulating activity of Streptococcus pneumoniae... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2443245